Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Trial ID or NCT#

NCT02178943

Status

not recruiting iconNOT RECRUITING

Purpose

Plasma donor-derived cell-free DNA (dd-cfDNA) is measured as a % of the total plasma cfDNA in association with the measurement of AlloMap, a non-invasive gene expression test to aid in heart transplant management.

Official Title

Utility of Donor-Derived Cell-free DNA in Association With Gene-Expression Profiling (AlloMap®) in Heart Transplant Recipients (D-OAR)

Eligibility Criteria

Ages Eligible for Study: Older than 15 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Show Less

Investigator(s)

Kiran Kaur Khush, MD
Kiran Kaur Khush, MD
Cardiologist, Heart failure cardiologist
Professor of Medicine (Cardiovascular Medicine)

Contact us to find out if this trial is right for you.

Contact

Helen Luikart
650-724-2883

View on ClinicalTrials.gov